CovalX

CovalX, established in 2006, is a leader in characterizing protein interactions through mass spectrometry. The company's innovative technologies and exclusive services cater to world-renowned Universities, therapeutic companies, and major pharmaceutical companies globally. CovalX AG specializes in measuring intact protein complexes using MALDI mass spectrometry, offering both tools and services for High-Mass MALDI protein-protein interaction analysis. The applications of their technology span from epitope mapping to characterizing aggregates from biotherapeutic drugs, analyzing antibody-antigen interactions, and rapidly characterizing protein complexes. Additionally, CovalX offers services for characterizing large macro molecules such as PEGylated proteins or polymers. Recently, the company restructured its operations, moving hardware support facilities and US sales and marketing to the Boston area, establishing an official subsidiary there. With a focus on the biotechnology, hardware, health care, pharmaceutical, and marketing industries, CovalX stands at the forefront of protein interaction analytics, employing mass spectrometry with the slogan "Protein Interaction Analytics. The accuracy of mass spectrometry for your biologics project."